top of page
World’s First Malaria Treatment for Newborns Approved
In a global health breakthrough, Novartis has gained Swiss approval for Coartem Baby, the first-ever malaria treatment for newborns. Specifically formulated for infants under 5 kg, the dissolvable, cherry-flavored medicine is set for fast-track approval in eight African nations, helping protect millions of vulnerable babies from malaria-related death.
Jul 10, 20253 min read
bottom of page